Organon

News

Sun Pharma says talk of $10bn Organon bid is 'speculative'

India's Sun Pharma has downplayed a rumour that it is in talks to acquire women's health specialist and MSD spinout Organon for $10bn.

News

Organon CEO resigns over 'improper' contraceptive sales

Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.

News

Black and white image of a man putting his finger to his lips to shush

AZ, Organon fall foul of UK's code on pharma promotion

AstraZeneca and Organon have breached the UK pharma industry's code of practice with promotions for an asthma drug and a contraceptive implant.

News

Organon makes dermatology play with $1.2bn Dermavant buyout

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis.

News

Samsung seeks 'interchangeable' label for Humira biosimilar

While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's

Sun Pharma says talk of $10bn Organon bid is 'speculative'

Organon CEO resigns over 'improper' contraceptive sales

AZ, Organon fall foul of UK's code on pharma promotion

Organon makes dermatology play with $1.2bn Dermavant buyout

Samsung seeks 'interchangeable' label for Humira biosimilar

Hernexeos and what’s next, with Vicky Brown

Using AI-driven synthetic personas to take your insights fur...

Organon

Editor's Picks